Six-factor-based stratification system for enfortumab vedotin monotherapy in pre-treated patients with metastatic or locally advanced urothelial carcinoma. (PubMed, World J Urol) - Sep 13, 2026 - "Six factors were identified as common prognostic factors for both PFS and OS in la/m UC patients receiving EV monotherapy. The newly developed prognostic risk stratification system based on these factors is clinically useful, particularly for predicting OS."
Journal • Monotherapy • Retrospective data • Endocrine Disorders • Hematological Disorders • Metabolic Disorders • Oncology • Solid Tumor • Urothelial Cancer • CRP
|
|
Atsushi Otsuka; Aya Niimi; Daichi Hirata; Daisuke Obinata; Gaku Ishikawa; Haruki Kume; Hayato Hoshina; Hideyo Miyazaki; Hiroaki Nishimatsu; Hiroki Kubota; Hiroshi Fukuhara; Hiroshi Furuse; Jimpei Miyakawa; Jun Kamei; Jun Takahashi; Keigo Sato; Kento Ozawa; Kosuke Uchida; Masao Nagata; Masashi Shiozaki; Michio Noda; Nobuhiko Shimizu; Nozomi Sugiyama; Ryo Sato; Satoru Taguchi; Satoru Takahashi; Satoshi Kurokawa; Sayuri Takahashi; Shigenori Kakutani; Shinya Watanabe; Takahiro Yasui; Takashi Murata; Takashi Nagai; Takehiro Tanaka; Taketo Kawai; Taku Naiki; Tappei Takada; Taro Murata; Teruo Inamoto; Tetsuya Fujimura; Tohru Nakagawa; Tomoyuki Kaneko; Toshiharu Morikawa; Toshiki Ito; Yohei Tsubouchi; Yoichi Mori; Yoshiyuki Akiyama; Yu Nakamura; Yuichi Kitagawa; Yukari Uemura; Yukihiro Umemoto; Yukihiro Yoshimi; Yukio Yamada; Yusuke Sato; Yuta Yamada; Yutaka Enomoto; Yuto Matsushita
|